Fallopian tube cancer begins in one or both of a woman's fallopian tubes. Risk for developing fallopian tube cancer occurs with increasing age, a family history, or with genetic mutations on the BRCA1 gene. Treatments for fallopian tube cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. If caught early, fallopian tube cancer can most likely be treated effectively, but as the cancer spreads to locations beyond the fallopian tubes, survival rates decrease. In stage 0 of fallopian tube cancer, the cancer has not moved to distant locations, there is no cancer in nearby lymph nodes. At this point, the cancer is also called carcinoma in situ. This is the earliest stage of fallopian tube cancer.
Stage 0 Fallopian Tube Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage 0 Fallopian Tube Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 836 products for the study of Stage 0 Fallopian Tube Cancer that can be applied to Flow Cytometry, Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.